Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

M.Video-Eldorado reported for 2024 by IFRS

4/30/25 MVID

Gazprom reports for 3 months of 2025 by RAS

4/30/25 GAZP

M.Video-Eldorado reported for 3 months 2025 by RAS

4/30/25 MVID

Lukoil reports for 3 months of 2025 by RAS

4/30/25 LKOH

Buryatzoloto reported for 3 months of 2025 by RAS

4/30/25 BRZL

Belon reported for 2024 by IFRS

4/30/25 BLNG

OMZ reported for 3 months of 2025 by RAS

4/30/25 OMZZP

Kaluga Sales Company reported for 3 months of 2025 by RAS

4/30/25 KLSB

Kamaz reported for the 3 months of 2025 by RAS

4/30/25 KMAZ

Transneft reported for 3 months of 2025 by RAS

4/30/25 TRNFP